<DOC>
	<DOCNO>NCT01961323</DOCNO>
	<brief_summary>To investigate whether treatment Nebivolol subject high blood pressure abnormal filling leave ventricle ( LVDD ) improve exercise time improve Left Ventricular deformation filling .</brief_summary>
	<brief_title>Effect Nebivolol Blood Flow Hearts Adults With High Blood Pressure Abnormal Filling Heart</brief_title>
	<detailed_description>Background : The left ventricle ( LV ) eject blood wring motion , LV apex rotates counterclockwise base rotates clockwise direction respectively . Rapid untwisting recoil LV isovolumic relaxation early diastole release energy store ejection LV suction rapid early diastolic restoration . The LV geometry rotational mechanic also give rise intracavitary blood flow rotation result LV intracavitary vortex ring formation . LV torsion vortex ring formation confer morphodynamic advantage gain importance blood flow velocity , heart rate rate change momentum increase exertion improve LV efficiency . We recently characterize significance LV twist mechanic vortex ring formation human heart use novel high resolution speckle contrast particle track echocardiography . Although data favorable effect nebivolol exercise capacity LV diastolic fill exists , change leave ventricular ( LV ) rotational mechanic blood flow vortex ring formation may explain potential hemodynamic benefit see nebivolol previously characterize . Aims : In patient hypertension leave ventricular diastolic dysfunction ( LVDD ) treatment nebivolol 6 month improves exercise time enhancing : 1 . LV deformation , torsion untwist mechanic 2 . LA-to-LV blood flow transport characteristic intra-cavitary vortex formation 3 . LA reservoir booster pump function LA-LV interaction conduit phase Hypotheses : Treatment nebivolol subject hypertension LVDD improve exercise time improve LV deformation diastolic fill . As diastole shortens tachycardia associate exercise , contribution untwist becomes relatively important LV suction filling . Nebivolol improve LV diastolic fill primarily enhance LV untwisting rheological efficiency blood flow transport vortex formation early diastole . Significance : Patients LVDD asymptomatic rest often become markedly symptomatic exertion . This pilot study provide data first time correlate improvement exercise capacity see use nebivolol change LV relaxation , torsional mechanic , LV vortex formation LA-LV transport function . The preliminary data essential understanding underlying pathophysiological mechanism nebivolol improves exercise hemodynamics besides provide data development subsequent large randomize multicentric trial .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>History mild ( 140160 / 90100 ) moderate ( 160200 / 100120 ) hypertension LV diastolic dysfunction ( &gt; /= Grade1 ) LV ejection fraction &gt; 50 % Indexed leave atrial volume &gt; /= 28 mL/m^2 In sinus rhythm time enrollment Willingness return 6month follow investigation Presence history follow baseline : 1 . History mitral valve disease great mild severity prosthetic mitral valve , congenital heart disease permanent pacemaker 2 . Calculated creatinine clearance &lt; 50 mL/min 3 . Terminal Illness expect Survival &lt; 1 year 4 . Previous Heart Transplant 5 . Individuals institutionalize 6 . Systolic BP &gt; 180 mm Hg diastolic BP &gt; 120 mm Hg Medical treatment elevate BP : 1 . Calcium channel blocker ( e.g . verapamil , nifedipine ) ; 2 . Alpha blocker ( e.g . prazosin ) ; 3 . Alpha agonist ( e.g . Î±methyldopa , hydralazine , clonidine ) Patient unwilling unable provide inform consent study participation Pregnancy ( current , anticipate within study period ) Secondary Hypertension Previous echo contrast allergy Poor echocardiography window Previous stroke , know carotid stenosis Contraindication betablocker therapy ( sinus bradycardia &lt; 50 beats/min ) ; 2nd 3rd degree AV conduction block Overt congestive cardiac failure ( NYHA Class IIIIV ) Known bronchospastic disease Known hepatic dysfunction ( SGOT/PT &gt; twice normal level )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>high blood pressure</keyword>
	<keyword>stress echocardiogram</keyword>
	<keyword>nebivolol</keyword>
	<keyword>leave ventricular diastolic dysfunction</keyword>
</DOC>